![Bernd Winterhalter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernd Winterhalter
Corporate Officer/Principal bij CureVac SE
Actieve functies van Bernd Winterhalter
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | 01-12-2019 | - |
Loopbaan van Bernd Winterhalter
Eerdere bekende functies van Bernd Winterhalter
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CUREVAC N.V. | Corporate Officer/Principal | 01-12-2019 | 01-02-2021 |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | 01-01-2018 |
Pharmacia GmbH | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 | 01-01-2003 |
Opleiding van Bernd Winterhalter
University of Freiburg | Doctorate Degree |
Statistieken
Internationaal
Duitsland | 6 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |
Pharmacia GmbH |
- Beurs
- Insiders
- Bernd Winterhalter
- Ervaring